Poziotinib in Stage IV Lung Adenocarcinoma With HER2 Mutation (KASTT001)
Clinical trial NCT02979821 · COMPLETED
Trial details
- NCT number
- NCT02979821
- Sponsor
- Korean Association for the Study of Targeted Therapy
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2017-12-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.